🇺🇸 FDA
Patent

US 9403800

Compounds for inhibition of cancer cell proliferation

granted A61KA61K31/4745A61K31/513

Quick answer

US patent 9403800 (Compounds for inhibition of cancer cell proliferation) held by ChemRegen, Inc. expires Mon Jul 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
ChemRegen, Inc.
Grant date
Tue Aug 02 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K31/4745, A61K31/513, A61K31/555, A61K31/635